Effects of hydroxychloroquine on proteinuria in membranous nephropathy

CONCLUSIONS: Hydroxychloroquine could be an option for patients with membranous nephropathy seeking to achieve proteinuria reduction and anti-PLA2R antibody reduction in addition to optimized RAASi. Randomized controlled trials are needed to confirm these findings.TRIAL REGISTRATION: ChiCTR2100045947, 20210430, retrospectively registered.PMID:34846713 | DOI:10.1007/s40620-021-01182-z

Source: Journal of Nephrology - November 30, 2021 Category: Urology & Nephrology Authors: Yan-Jiao Cheng Xu-Yang Cheng Yi-Miao Zhang Fang Wang Xin Wang Li-Qiang Meng Gang Liu Zhao Cui Ming-Hui Zhao Source Type: research